| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 15 May 2025 | 7 May 2025 |
| Abbott India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2025 inter alia to consider and approve Audited Financial Results of the Company for the quarter and financial year ended March 31 2025. Outcome of Board Meeting (As Per BSE Announcement Dated on: 15/05/2025) | ||
| Board Meeting | 7 May 2025 | 7 May 2025 |
| Appointment of Managing Director | ||
| Board Meeting | 18 Apr 2025 | 18 Apr 2025 |
| Appointment of Chief Financial Officer | ||
| Board Meeting | 5 Feb 2025 | 28 Jan 2025 |
| ABBOTT INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2025 inter alia to consider and approve the Unaudited Financial Results for quarter and nine months ended December 31 2024. Outcome of Board Meeting (As Per BSE Announcement Dated on: 05/02/2025) | ||
| Board Meeting | 7 Nov 2024 | 28 Oct 2024 |
| Quarterly Results Outcome of Board Meeting (As Per BSE Announcement Dated on 07.11.2024) | ||
| Board Meeting | 7 Aug 2024 | 30 Jul 2024 |
| ABBOTT INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2024 inter alia to consider and approve the Unaudited Financial Results of the Company for the first quarter ended on June 30 2024. Further please note that in terms of Abbott India Code of Internal Procedures and Conduct for Regulating Monitoring and Reporting of Trading by Insiders and in accordance with the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015 and further to our intimation dated June 26 2024 the Trading Window of the Company remains closed from Monday July 1 2024 to Friday August 9 2024 (both days inclusive). Unaudited Financial Results of the Company for the first quarter ended on June 30, 2024 (As per BSE Announcement Dated on 07/08/2024) | ||
Sitagliptin has played a crucial role in managing type 2 diabetes by lowering HbA1c levels and improving blood sugar control.
Here are some of the stocks that may see significant price movement today: Jio Financial Service, Hero MotoCorp, Abbott India, etc.
The Board of Directors has recommended Final Dividend of ₹ 475 per equity share (of Face Value ₹10/- each) for the year ended March 31, 2025.
Here are some of the stocks that may see significant price movement today: JSW Energy, Abbott India, Patanjali Foods, etc.
EBITDA increased by 10.2% to ₹391.1 Crore in the first quarter of this fiscal year, up from ₹355 Crore the previous year.
Here are some of the stocks that may see significant price movement today: Godrej Consumer Products, Hindalco Industries, Abbott India, etc.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
